Skip to main content

Articles

Page 1 of 332

  1. This study aimed to explore the effect of CD276 expression on the sunitinib sensitivity of clear cell renal cell carcinoma (ccRCC) cell and animal models and the potential mechanisms involved.

    Authors: Zhi-yu Zhang, Jian-hao Xu, Jiang-lei Zhang, Yu-xin Lin and Jun Ou-Yang
    Citation: BMC Cancer 2024 24:650
  2. Neoadjuvant immune checkpoint blockade (ICB) combined with chemoradiotherapy offers high pathologic complete response (pCR) rate for patients with locally advanced esophageal squamous cell carcinomas (ESCC). B...

    Authors: Dan-Dan Zheng, Yu-Ying Li, Xiao-Yi Yuan, Jiang-Li Lu, Mei-Fang Zhang, Jia Fu and Chris Zhiyi Zhang
    Citation: BMC Cancer 2024 24:649
  3. This study aimed to assess the long-term effect of level IIb clinical target volume (CTV) optimisation on survival, xerostomia, and dysphagia in patients with nasopharyngeal carcinoma (NPC).

    Authors: Jiawei Zhou, Li Wang, Ting Qiu, Han Gao, Lijun Wang, Shengfu Huang, Xia He and Lirong Wu
    Citation: BMC Cancer 2024 24:648
  4. Patient satisfaction is an important indicator of the quality of healthcare. Pain is one of the most common symptoms among cancer patients that needs optimal treatment; rather, it compromises the quality of li...

    Authors: Molla Amsalu, Henos Enyew Ashagrie, Amare Belete Getahun and Yophtahe Woldegerima Berhe
    Citation: BMC Cancer 2024 24:647
  5. Radiotherapy interruption (RTI) prolongs the overall total treatment time and leads to local control loss in many cancers, but it is unclear in esophageal cancer. We aimed to evaluate the influence of RTI on t...

    Authors: Yanhong Mou, Peng Liang, Xun Cheng, Xin He, Jun Zhang, Liangzhong Liu and Qiang Liu
    Citation: BMC Cancer 2024 24:646
  6. Cerebellar degeneration-related (CDR) proteins are associated with paraneoplastic cerebellar degeneration (PCD) – a rare, neurodegenerative disease caused by tumour-induced autoimmunity against neural antigens...

    Authors: Eirik Tveit Solheim, Yola Gerking, Torbjørn Kråkenes, Ida Herdlevær, Even Birkeland, Cecilie Totland, Fiona Dick and Christian Alexander Vedeler
    Citation: BMC Cancer 2024 24:645
  7. Understanding the metabolic changes in colorectal cancer (CRC) and exploring potential diagnostic biomarkers is crucial for elucidating its pathogenesis and reducing mortality. Cancer cells are typically deriv...

    Authors: Xuancheng Wang, Xuan Guan, Ying Tong, Yunxiao Liang, Zongsheng Huang, Mingsen Wen, Jichu Luo, Hongwei Chen, Shanyi Yang, Zhiyong She, Zhijuan Wei, Yun Zhou, Yali Qi, Pingchuan Zhu, Yanying Nong and Qisong Zhang
    Citation: BMC Cancer 2024 24:644
  8. The proposed trial is to examine the feasibility of prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT)-guided cytoreduction plus apalutamide and androgen depriv...

    Authors: Beihe Wang, Jian Pan, Tingwei Zhang, Xudong Ni, Yu Wei, Xiaomeng Li, Bangwei Fang, Xiaoxin Hu, Hualei Gan, Junlong Wu, Hongkai Wang, Dingwei Ye and Yao Zhu
    Citation: BMC Cancer 2024 24:643
  9. PD-L1 was an important biomarker in lung adenocarcinoma. The study was to confirm the most important factor affecting the expression of PD-L1 remains undetermined.

    Authors: Fang Lu, Ernuo Wang and Haiquan Liu
    Citation: BMC Cancer 2024 24:642
  10. HER2-positive, estrogen receptor-positive breast cancer (HER2+, ER+ BC) is a distinct disease subtype associated with inferior response to chemotherapy plus HER2-targeted therapy compared with HER2+, ER-negati...

    Authors: Sherko Kuemmel, Catherine Harper-Wynne, Yeon Hee Park, Fábio Franke, Michelino de Laurentiis, Eva Schumacher-Wulf, Daniel Eiger, Sarah Heeson, Andrés Cardona, Özgür Özyilkan, Flavia Morales-Vàsquez, Ciara Metcalfe, Marc Hafner, Eleonora Restuccia and Joyce O’Shaughnessy
    Citation: BMC Cancer 2024 24:641
  11. Pediatric Acute Myeloid Leukemia (AML) is a major cause of morbidity and mortality in children with cancer in Africa and other developing continents. Systemic chemotherapy and effective supportive care have si...

    Authors: Wudinesh Mamo, Ayalew Moges, Subah Abderehim Yesuf, Abdulkadir Mohamedsaid and Gashaw Arega
    Citation: BMC Cancer 2024 24:640
  12. Breast cancer patients often have a poor prognosis largely due to lack of effective targeted therapy. It is now well established that monosaccharide enhances growth retardation and chemotherapy sensitivity in ...

    Authors: Shilong Yu, Zhaoyi Yue and Qilun Liu
    Citation: BMC Cancer 2024 24:639
  13. Emerging evidence suggests the dysregulation of long non-coding RNAs (lncRNAs) involved in pancreatic cancer (PC). However, the function of LINC00930 in PC has not been elaborated. In this study, we found that...

    Authors: Yingqing Mao, Xian Su, Qingsong Guo, Xihao Yao, Qun Zhao, Yibing Guo, Yao Wang, Xiaohong Li and Yuhua Lu
    Citation: BMC Cancer 2024 24:638
  14. Brachytherapy has been indicated as an alternative option for treating cystic craniopharyngiomas (CPs). The potential benefits of brachytherapy for CPs have not yet been clarified. The purpose of this work was...

    Authors: Li-Yuan Zhang, Wei Guo, Han-Ze Du, Hui Pan, Yun-Chuan Sun, Hui-Juan Zhu, Shuai-Hua Song, Xiao-Yuan Guo, Yue Jiang and Qian-Qian Sun
    Citation: BMC Cancer 2024 24:637
  15. Neuroendocrine carcinoma (NEC) originating from the endometrium is rare, and there is limited knowledge regarding its diagnosis and optimal management. In this study, we present our experience with 11 patients...

    Authors: Xueyan Liu, Yanpeng Tian, Shuping Yan, Hanlin Fu, Lulu Si, Tianjiao Lai, Meng Mao, Qian Wang, Jing Bai, Heli Li and Ruixia Guo
    Citation: BMC Cancer 2024 24:636
  16. Adenocarcinoma of the ampulla of Vater (AoV) is one of the rare periampullary cancers, and due to its anatomical location, it is categorized into various histologic subtypes. Its rarity and diversity pose chal...

    Authors: Seunghwan Lee, Se Jun Park, Kabsoo Shin, Tae Ho Hong, In-Ho Kim and Myung Ah Lee
    Citation: BMC Cancer 2024 24:634
  17. PD-L1 overexpression is commonly observed in various malignancies and is strongly correlated with poor prognoses for cancer patients. Moreover, PD-L1 has been shown to play a significant role in promoting angi...

    Authors: Wenjuan Li, Jiatao Wu, Qianhao Jia, Yuqi Shi, Fan Li, Linxiang Zhang, Fan Shi, Xiaojing Wang and Shiwu Wu
    Citation: BMC Cancer 2024 24:633
  18. Patients with irresectable stage III or metastatic melanoma presenting with poor prognostic factors are usually treated with a combination of immune checkpoint inhibitors (ICIs), consisting of ipilimumab and n...

    Authors: J. C. Janssen, B. van Dijk, K. de Joode, M. J. B. Aarts, F. W. P. J. van den Berkmortel, C. U. Blank, M. J. Boers-Sonderen, A. J. M. van den Eertwegh, J. W. B. de Groot, M. Jalving, M. J. A. de Jonge, A. Joosse, E. Kapiteijn, A. M. Kamphuis-Huismans, K. A. T. Naipal, D. Piersma…
    Citation: BMC Cancer 2024 24:632
  19. Cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i) combined with endocrine therapy (ET) are currently recommended by the National Comprehensive Cancer Network (NCCN) guidelines and the European Society for M...

    Authors: Veronique Lambert, Sarah Kane, Belal Howidi, Bao-Ngoc Nguyen, David Chandiwana, Yan Wu, Michelle Edwards and Imtiaz A. Samjoo
    Citation: BMC Cancer 2024 24:631
  20. Tumor morphology, immune function, inflammatory levels, and nutritional status play critical roles in the progression of intrahepatic cholangiocarcinoma (ICC). This multicenter study aimed to investigate the a...

    Authors: Haofeng Zhang, Guan Huang, Qingshan Li, Yanbo Wang, Zhenwei Yang, Pengyu Chen, Hao Yuan, Kunlun Chen, Bo Meng and Haibo Yu
    Citation: BMC Cancer 2024 24:630
  21. The 17-gene Genomic Prostate Score (GPS) test has been clinically employed to predict adverse prognosis in prostate cancer. In this meta-analysis, we aimed to evaluate the prognostic value of the 17-gene GPS i...

    Authors: Feilun Cui, Xuan Tang, Changfeng Man and Yu Fan
    Citation: BMC Cancer 2024 24:628
  22. CCR8-expressing regulatory T cells (Tregs) are selectively localized within tumors and have gained attention as potent suppressors of anti-tumor immunity. This study focused on CCR8+ Tregs and their interaction w...

    Authors: Yoshinori Hayashi, Azumi Ueyama, Soichiro Funaki, Koichi Jinushi, Naoko Higuchi, Hitomi Morihara, Michinari Hirata, Yoji Nagira, Takuro Saito, Atsunari Kawashima, Kota Iwahori, Yasushi Shintani and Hisashi Wada
    Citation: BMC Cancer 2024 24:627
  23. Cervical cancer is a tumor with high morbidity and mortality. The importance of inflammatory and metabolic parameters affecting progression-free survival (PFS) and overall survival (OS) has been investigated m...

    Authors: Mehmet Emin Buyukbayram, Zekeriya Hannarici, Aykut Turhan, Alperen Akansel Caglar, Pınar Çoban Esdur, Mehmet Bilici, Salim Basol Tekin and Burak Erdemci
    Citation: BMC Cancer 2024 24:626
  24. Obesity is associated with chronic low-grade inflammation, which is linked to cancer development. Abdominal obesity (a body mass index, ABSI), however, has unusually been associated inversely with cutaneous ma...

    Authors: Sofia Christakoudi, Konstantinos K. Tsilidis and Elio Riboli
    Citation: BMC Cancer 2024 24:625
  25. Hepatocellular carcinoma (HCC) has a high mortality rate, and the mechanisms underlying tumor development and progression remain unclear. However, inactivated tumor suppressor genes might play key roles. DNA m...

    Authors: Yuanxiao Du, Yuqiu Xu, Xuefeng Guo, Chao Tan, Xiaonian Zhu, Guoyu Liu, Xiao Lyu and Chunhua Bei
    Citation: BMC Cancer 2024 24:624
  26. International guidelines recommend ivosidenib followed by modified FOLFOX (mFOLFOX) for advanced intrahepatic cholangiocarcinoma (ICC) with isocitrate dehydrogenase 1 (IDH1) mutations. Taiwan National Health Insu...

    Authors: Kuei-An Chen, Wei-Ming Huang, Eric Yi-Ting Chen, Pei-Kuan Ho, Chen-Han Chueh, Yu-Wen Wen, Ming-Huang Chen, Nai-Jung Chiang and Yi-Wen Tsai
    Citation: BMC Cancer 2024 24:622
  27. Diffuse large B-cell lymphomas (DLBCLs) display high molecular heterogeneity, but the International Prognostic Index (IPI) considers only clinical indicators and has not been updated to include molecular data....

    Authors: Huilin Peng, Mengmeng Su, Xiang Guo, Liang Shi, Tao Lei, Haifeng Yu, Jieyu Xu, Xiaohua Pan and Xi Chen
    Citation: BMC Cancer 2024 24:621
  28. The role of adjuvant transcatheter arterial chemoembolization (TACE) following repeated resection/ablation for recurrent hepatocellular carcinoma (HCC) remains uncertain. The aim of this study was to assess th...

    Authors: Kaiquan Huang, Tao Qian, Wen Chen, Mengyi Lao, Huiliang Li, Wei-Chiao Lin, Bryan Wei Chen, Xueli Bai, Shunliang Gao, Tao Ma and Tingbo Liang
    Citation: BMC Cancer 2024 24:620
  29. Breast cancer is one of the common malignancies in women. Evidence has demonstrated that FBXO45 plays a pivotal role in oncogenesis and progression. However, the role of FBXO45 in breast tumorigenesis remains ...

    Authors: Mengmeng Zheng, Linfeng Wu, Rongyao Xiao, Jiaohao Cai, Weike Chen and Shurong Shen
    Citation: BMC Cancer 2024 24:619
  30. Hepatocellular carcinoma (HCC) presents a significant threat to individuals and healthcare systems due to its high recurrence rate. Accurate prognostic models are essential for improving patient outcomes. Gamm...

    Authors: Mingxiu Ma, Kailing Xie, Tianqiang Jin and Feng Xu
    Citation: BMC Cancer 2024 24:617
  31. DNA-Damaged Binding protein 2 (DDB2) is a protein involved in the early step of Nucleotide Excision Repair. Recently, it has been reported that DDB2 is involved in epithelial-to-mesenchymal transition (EMT), k...

    Authors: Paola Perucca, Elisabetta Bassi, Martina Vetro, Anna Tricarico, Ennio Prosperi, Lucia Anna Stivala and Ornella Cazzalini
    Citation: BMC Cancer 2024 24:616
  32. Breast cancer (BC) is the most commonly diagnosed cancer in women. Treatment approaches that differ between estrogen-positive (ER+) and triple-negative BC cells (TNBCs) and may subsequently affect cancer bioma...

    Authors: Rita El Habre, Rita Aoun, Roula Tahtouh and George Hilal
    Citation: BMC Cancer 2024 24:615
  33. Our study was to investigate the impact of taurolactone, a novel anti-tumor and anti-angiogenic drug, on AGGF1, an angiogenic factor, and angiogenesis mimicry in patients diagnosed with hepatocellular carcinom...

    Authors: Shaoping Liu, Yinzhi Wei, Lei Nie, Ze Tang, Qi Lu and Qun Liang
    Citation: BMC Cancer 2024 24:614
  34. The intricate balance between the advantages and risks of low-dose computed tomography (LDCT) impedes the utilization of lung cancer screening (LCS). Guiding shared decision-making (SDM) for well-informed choi...

    Authors: Xiujing Lin, Fangfang Wang, Yonglin Li, Fang Lei, Weisheng Chen, Rachel H. Arbing, Wei-Ti Chen and Feifei Huang
    Citation: BMC Cancer 2024 24:613
  35. Glioblastoma multiforme (GBM) is a type of fast-growing brain glioma associated with a very poor prognosis. This study aims to identify key genes whose expression is associated with the overall survival (OS) i...

    Authors: Parisa Azimi, Taravat Yazdanian and Abolhassan Ahmadiani
    Citation: BMC Cancer 2024 24:612
  36. RNA interactomes and their diversified functionalities have recently benefited from critical methodological advances leading to a paradigm shift from a conventional conception on the regulatory roles of RNA in...

    Authors: Jing-Yu Wang, Xiao-Ping Zhang, Hong-Kun Zhou, Hong-Xin Cai, Jin-Biao Xu, Bao-Gang Xie, Jean-Paul Thiery and Wu Zhou
    Citation: BMC Cancer 2024 24:611
  37. Venous thromboembolism (VTE) is a major complication of breast cancer surgical patients. Assessing VTE awareness enables medical staff to tailor educational programs that improve patient self-management and re...

    Authors: Qiuzhou Wang, Hongxiu Chen, Qingyu Yang, Jiajia Qiu, Sijin Guo, Yi Zhou, Lihong Huang, Chen Li and Xiaoxia Zhang
    Citation: BMC Cancer 2024 24:610
  38. The modeled CA-125 elimination constant K (KELIM) is a potential marker of tumor chemosensitivity in ovarian cancer patients treated with neoadjuvant chemotherapy (NACT) before interval surgery. The objective ...

    Authors: Cheng Li, Qiulin Cui, Xuanhui Wang, Shuzhong Yao, Hua Tu and Ming Chen
    Citation: BMC Cancer 2024 24:609
  39. Lung cancer is the second most diagnosed cancer in the world. Up to 84% of diagnosed patients have malnutrition, which can negatively affect quality of life and survival and may worsen with neoadjuvant treatme...

    Authors: Melania Prete, Giada Ballarin, Giuseppe Porciello, Aniello Arianna, Assunta Luongo, Valentina Belli, Luca Scalfi and Egidio Celentano
    Citation: BMC Cancer 2024 24:608
  40. Cancer is a leading global cause of death. Conventional cancer treatments like surgery, radiation, and chemotherapy have associated side effects. Ferroptosis, a nonapoptotic and iron-dependent cell death, has ...

    Authors: Shen Li, Kai Tao, Hong Yun, Jiaqing Yang, Yuanling Meng, Fan Zhang and Xuelei Ma
    Citation: BMC Cancer 2024 24:604
  41. Immunotherapy or apatinib alone has been used as third-line adjuvant therapy for advanced or metastatic gastric/gastroesophageal junction (G/GEJ) tumors, but the efficacy of combining them with each other for ...

    Authors: Jincheng Wang, Jie Lin, Ruimin Wang, Ti Tong and Yinghao Zhao
    Citation: BMC Cancer 2024 24:603
  42. Chronic obstructive pulmonary disease (COPD) is a significant global health issue, suspected to elevate the risk for various cancers. This study sought to discern whether COPD serves as a risk marker or a caus...

    Authors: Shixia Liao, Yanwen Wang, Jian Zhou, Yuting Liu, Shuangfei He, Lanying Zhang, Maomao Liu, Dongmei Wen, Pengpeng Sun, Guangbing Lu, Qi Wang, Yao Ouyang and Yongxiang Song
    Citation: BMC Cancer 2024 24:601
  43. Exercise-based cancer rehabilitation via digital technologies can provide a promising alternative to centre-based exercise training, but data for cancer patients and survivors are limited. We conducted a meta-...

    Authors: Ladislav Batalik, Katerina Chamradova, Petr Winnige, Filip Dosbaba, Katerina Batalikova, Daniela Vlazna, Andrea Janikova, Garyfallia Pepera, Hammoda Abu-Odah and Jing Jing Su
    Citation: BMC Cancer 2024 24:600

Featured videos

View featured videos from across the BMC-series journals